(Q43750140)

26 November 2017

title

Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis? (English)

1 reference

26 November 2017

1 reference

Kremer B

1

1 reference

26 November 2017

Klimek L

series ordinal

2

1 reference

26 November 2017

Bullinger M

series ordinal

3

1 reference

26 November 2017

Mösges R

series ordinal

4

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

56

1 reference

26 November 2017

issue

10

1 reference

26 November 2017

page(s)

957-963

1 reference

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

Antiallergic activity of loratadine, a non-sedating antihistamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

Measuring health-related quality of life in rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

Impact on quality of life during an allergen challenge research trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

7 January 2021

[Reliability and validity of the Visual Analogue Scale (VAS) (author's transl)]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

7 January 2021

Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

7 January 2021

Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

7 January 2021

Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00919.X

7 January 2021

10.1034/J.1398-9995.2001.00919.X

Identifiers

DOI

1 reference

26 November 2017

1 reference